secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0000950170-22-025876
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences appoints Thomas Schaefer as CFO, succeeding Pamela Haley
----------------------------------------------------------------------------

- Pamela Haley resigns as CFO effective January 3, 2023; will stay in advisory role.
- Thomas J. Schaefer, current VP of Finance and IR, promoted to CFO effective same date.
- Schaefer has 20+ years finance experience, previously at Flavor Producers and Edward Jones, holds CFA.
- Schaefer led commercial launch of GoodWheat and development of long-term strategy Project Greenfield.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/0000950170-22-025876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/rkda-20221128.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer